Test Price
700 AED✅ Home Collection Available
Haemophilus influenzae RNA Detection (Qualitative) in UAE | 700 AED | DHA Licensed Molecular Diagnostics
Executive Summary & Core Metrics
Diagnostic Accuracy: Analytical sensitivity exceeding 99.9% via ISO 9001:2015 certified processing (Certificate No. INT/EGQ/2509DA/3139).
Logistical Infrastructure: Hospital extraction only – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Temperature-controlled cold-chain transport from facility to laboratory.
Clinical Support: Complimentary telephonic consultation with a licensed medical professional following result delivery to interpret findings and guide next steps.
Insurance & Scheduling: Direct insurance coverage verification via WhatsApp at +971 54 548 8731 (daily 8 AM – 11 PM).
Protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). Full data confidentiality guaranteed.
Test Overview & Methodology
The Haemophilus influenzae RNA Detection Qualitative test identifies active bacterial H. influenzae infection with near-perfect precision using Real-Time PCR (RT‑qPCR) targeting ribosomal RNA. Results guide timely antibiotic therapy or rule-out of invasive disease in sterile fluid specimens.
This molecular assay detects the pathogen even before culture growth becomes detectable, making it critical for suspected meningitis (cerebrospinal fluid), pneumonia (bronchial lavage), or epiglottitis. Clinicians order it when symptoms suggest invasive disease and rapid diagnosis can prevent severe complications.
| Feature | Our Test (RT‑qPCR RNA) | Closest Alternative (Culture/Ag) |
|---|---|---|
| Precision | >99% analytical sensitivity & specificity | Variable; delayed growth, false negatives |
| Method | Real‑Time PCR (RT‑qPCR), confirmable WGS | Bacterial culture, antigen detection |
| Time to Result | Urgent verbal: 24 hours; formal report: 3rd working day | Culture: 3–7 days; antigen: few hours (lower sensitivity) |
Physician Insight & Safety Protocols
“As a molecular genetics specialist, I recognise the clinical urgency when invasive H. influenzae disease is suspected. This RNA-targeted RT‑qPCR assay provides definitive molecular evidence to initiate directed antimicrobial therapy without the delays inherent to culture-based methods. Clinicians must integrate molecular results with the full clinical picture — no laboratory test replaces comprehensive physical assessment and medical judgement.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Do not discontinue or alter prescribed antibiotic therapy without explicit instruction from your treating physician. Antibiotic use within 48 hours prior to sample collection may reduce RNA detection sensitivity; however, patient safety takes precedence over test optimisation. Always consult your doctor before making any medication changes.
Safety Exclusion Criteria & Red Flags
- Exclusion: Inability to provide signed informed consent or complete clinical history as required by DHA regulatory standards under Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Exclusion: Inappropriate sample type (e.g., routine throat swab without visible purulent material) — only cerebrospinal fluid, bronchial swabs, or bronchoalveolar lavage are accepted for this assay.
- Emergency Red Flag: Severe respiratory distress, confusion, stiff neck, or high fever with petechial rash — proceed immediately to the nearest emergency department; do not wait for test collection.
- Emergency Red Flag: Suspected meningitis or epiglottitis in paediatric patients — refer urgently to an accredited paediatric emergency centre for immediate clinical evaluation and stabilisation.
Patient FAQ & Clinical Guidance
1. What does the Haemophilus influenzae RNA test detect and why is it ordered?
Snippet: It detects bacterial RNA from active H. influenzae infection in sterile fluids, guiding urgent antibiotic decisions.
This qualitative RT‑qPCR identifies the pathogen even before culture growth, making it critical for suspected meningitis (from CSF), pneumonia (bronchial lavage), or epiglottitis. Clinicians order it when symptoms suggest invasive disease and rapid diagnosis can prevent severe complications such as sepsis or airway compromise.
2. How should I prepare for the sample collection, and are there any special instructions?
Snippet: No fasting required; bring your clinical history and signed consent form to the collection appointment.
Hospital extraction only — sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. For CSF, a hospital lumbar puncture is performed by qualified medical staff. For bronchial specimens, coordinate directly with your pulmonologist. Avoid antibiotics 48 hours prior if clinically safe, as they may reduce RNA detection sensitivity; however, never stop prescribed antibiotics without your doctor’s advice.
3. When will I receive my results, and how can I use them with my doctor?
Snippet: Urgent verbal result within 24 hours; formal email report by the 3rd working day.
You will receive a phone call with the qualitative finding as soon as the PCR run completes, typically within 24 hours for emergency cases. The certified PDF report follows within 36–72 hours. All reports include our DHA-compliant interpretation guide. Use the provided telephonic consultation to discuss clinical correlation with your treating physician and to determine the appropriate therapeutic course.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
This diagnostic service operates in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing all patient data handling, storage, and processing.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — regulating telehealth, digital records, and electronic data exchange.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — establishing patient safety standards, consent requirements, and clinical accountability.
Laboratory operations are certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and licensed by the Dubai Health Authority as facility number 1143. All clinical guidance is provided by DHA-licensed Consultant Medical Genetics Lina Osama Zaki Quteineh (Registration ID: 9294403). For insurance verification or logistical coordination, WhatsApp +971 54 548 8731 (daily 8 AM – 11 PM).
Clinical & Logistical Metadata
| Test Name | Haemophilus influenzae RNA Detection (Qualitative) |
| Price (AED) | 700 AED |
| Turnaround Time | Urgent verbal result within 24 hours; formal email report by the 3rd working day |
| Sample Type / Matrix | Cerebrospinal Fluid (CSF), Bronchial Swab, or Bronchoalveolar Lavage — Hospital Extraction Only; mobile home phlebotomy is disabled for safety |
| Methodology Used | Real-Time PCR (RT‑qPCR) targeting ribosomal RNA; confirmable by whole-genome sequencing |
| ICD-10-CM Code | B96.3, A49.2 |
| LOINC Code | 31762-3 |
| DHA Facility License & Laboratory Address | Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians